A detailed history of Appleton Partners Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Appleton Partners Inc holds 4,888 shares of LLY stock, worth $3.88 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
4,888
Previous 4,946 1.17%
Holding current value
$3.88 Million
Previous $4.48 Million 3.31%
% of portfolio
0.32%
Previous 0.34%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 01, 2024

SELL
$772.14 - $960.02 $44,784 - $55,681
-58 Reduced 1.17%
4,888 $4.33 Million
Q2 2024

Jul 02, 2024

SELL
$724.87 - $909.04 $92,058 - $115,448
-127 Reduced 2.5%
4,946 $4.48 Million
Q1 2024

Apr 01, 2024

SELL
$592.2 - $792.28 $175,291 - $234,514
-296 Reduced 5.51%
5,073 $3.95 Million
Q4 2023

Jan 02, 2024

SELL
$525.19 - $619.13 $55,144 - $65,008
-105 Reduced 1.92%
5,369 $3.13 Million
Q3 2023

Oct 03, 2023

SELL
$434.7 - $599.3 $226,913 - $312,834
-522 Reduced 8.71%
5,474 $2.94 Million
Q2 2023

Jul 10, 2023

SELL
$350.74 - $468.98 $24,551 - $32,828
-70 Reduced 1.15%
5,996 $2.81 Million
Q1 2023

Apr 10, 2023

SELL
$310.63 - $364.82 $46,905 - $55,087
-151 Reduced 2.43%
6,066 $2.08 Million
Q4 2022

Jan 19, 2023

SELL
$321.55 - $374.67 $96,786 - $112,775
-301 Reduced 4.62%
6,217 $2.27 Million
Q3 2022

Oct 27, 2022

SELL
$296.48 - $337.87 $29,648 - $33,787
-100 Reduced 1.51%
6,518 $2.11 Million
Q2 2022

Jul 08, 2022

BUY
$278.73 - $327.27 $35,398 - $41,563
127 Added 1.96%
6,618 $2.15 Million
Q1 2022

Apr 05, 2022

SELL
$234.69 - $291.66 $34,030 - $42,290
-145 Reduced 2.19%
6,491 $1.86 Million
Q4 2021

Feb 03, 2022

SELL
$224.85 - $279.04 $16,863 - $20,928
-75 Reduced 1.12%
6,636 $1.83 Million
Q3 2021

Oct 14, 2021

SELL
$221.6 - $272.71 $52,076 - $64,086
-235 Reduced 3.38%
6,711 $1.55 Million
Q2 2021

Jul 07, 2021

BUY
$180.55 - $233.54 $129,996 - $168,148
720 Added 11.56%
6,946 $1.59 Million
Q1 2021

Apr 19, 2021

SELL
$164.32 - $212.72 $1,643 - $2,127
-10 Reduced 0.16%
6,226 $1.16 Million
Q4 2020

Jan 19, 2021

BUY
$130.46 - $172.63 $20,873 - $27,620
160 Added 2.63%
6,236 $1.05 Million
Q3 2020

Oct 14, 2020

SELL
$146.22 - $169.13 $21,933 - $25,369
-150 Reduced 2.41%
6,076 $899,000
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $27,283 - $32,836
-200 Reduced 3.11%
6,226 $1.02 Million
Q1 2020

May 04, 2020

BUY
$119.05 - $147.35 $192,861 - $238,707
1,620 Added 33.71%
6,426 $891,000
Q4 2019

Jan 13, 2020

SELL
$106.92 - $132.43 $55,384 - $68,598
-518 Reduced 9.73%
4,806 $632,000
Q2 2019

Jul 25, 2019

BUY
$110.79 - $129.32 $25,481 - $29,743
230 Added 4.52%
5,324 $590,000
Q1 2019

Apr 17, 2019

SELL
$111.31 - $131.02 $16,139 - $18,997
-145 Reduced 2.77%
5,094 $661,000
Q4 2018

Jan 17, 2019

SELL
$105.9 - $118.64 $42,042 - $47,100
-397 Reduced 7.04%
5,239 $606,000
Q3 2018

Oct 09, 2018

SELL
$85.86 - $107.31 $38,379 - $47,967
-447 Reduced 7.35%
5,636 $605,000
Q2 2018

Aug 08, 2018

SELL
$75.7 - $86.88 $66,464 - $76,280
-878 Reduced 12.61%
6,083 $519,000
Q1 2018

Apr 11, 2018

BUY
$74.21 - $87.6 $4,823 - $5,694
65 Added 0.94%
6,961 $539,000
Q4 2017

Jan 12, 2018

BUY
$81.94 - $87.89 $11,061 - $11,865
135 Added 2.0%
6,896 $582,000
Q3 2017

Oct 12, 2017

BUY
$77.07 - $85.54 $521,070 - $578,335
6,761
6,761 $578,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Appleton Partners Inc Portfolio

Follow Appleton Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Appleton Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Appleton Partners Inc with notifications on news.